Literature DB >> 31763797

Gram-Scale Preparation of C-Terminal-Modified Enkephalin Analogues by Typical Liquid-Phase Peptide Synthesis.

Yeon Sun Lee1.   

Abstract

This article describes the gram-scale liquid-phase peptide synthesis of C-terminal-modified enkephalin analogues that possess high analgesic efficacy in animals, high potency for mu and delta opioid receptors, and high metabolic stability and potential blood-brain barrier permeability. Despite the long cycle time and tedious purification steps, liquid-phase synthesis is still a preferred method for large-scale peptide synthesis due to its cost effectiveness (i.e., amount of amino acids and reagents required), easy detection, and isolation of impurities compared with solid-phase synthesis. A robust liquid-phase synthesis protocol is described, involving BOP-assisted coupling and Boc deprotection, which has been well established in the laboratory and is a useful synthetic protocol for cost-effective production of peptide drugs.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  BOP-assisted coupling; Boc chemistry; C-terminal-modified enkephalins; liquid-phase peptide synthesis; opioid receptors

Mesh:

Substances:

Year:  2019        PMID: 31763797     DOI: 10.1002/cpps.97

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  2 in total

1.  C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters.

Authors:  Munawar A Munawar; David Rankin; Victor J Hruby; Frank Porreca; Yeon Sun Lee
Journal:  Bioorg Med Chem       Date:  2021-11-11       Impact factor: 3.641

2.  Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism.

Authors:  Yeon Sun Lee; Michael Remesic; Cyf Ramos-Colon; Zhijun Wu; Justin LaVigne; Gabriella Molnar; Dagmara Tymecka; Aleksandra Misicka; John M Streicher; Victor J Hruby; Frank Porreca
Journal:  Biomedicines       Date:  2021-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.